Hamostaseologie

Article	Citations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	63
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)	35
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	22
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	19
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	18
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	17
	16
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	16
A novel assay to quantify extrinsic tenase complexes in body fluids	13
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays	13
ITAM upregulation in platelets after major surgery	13
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome	12
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses	12
	11
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms	11
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)	10
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)	10
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism	9
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis	9
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports	8
Platelets in Myocardial Ischemia/Reperfusion Injury	7
Subsegmental Pulmonary Embolism	7
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	7
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	7
Komplementdysregulation als Biomarker für Post Covid	7

Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?	7
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	7
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	7
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	7
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease	6
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	6
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome	6
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)	6
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome	6
Increased transfusion requirement in children compared to adults undergoing cardiac surgery	6
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	6
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells	6
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score	5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	5
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey	5
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	5
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice	5
Management of Antithrombin Deficiency in Pregnancy	5
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	5
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin	5
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	4
GTH News	4
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets	4
Reference Intervals in Coagulation Analysis	4
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	4
Influence of coagulation proteases on cognitive function	4
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	4
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	4
Venous Thrombosis and SARS-CoV-2	4
Familial Protein S deficiency with severe venous thromboembolism (VTE)	4
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing	4
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	3
Acquired von Willebrand Syndrome in Children	3
A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis	3
Bleeding Risk in Patients with Cancer	3
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis	3
	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	3
Update des Versorgungsvertrages nach § 132 i SGBV	3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop	3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	3
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model	3
The Use of Large Animal Models in Trauma and Bleeding Studies	3
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification	3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	3
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien	3
Communication in Healthcare: Global challenges in the 21st Century	3
Treatment of Inherited Platelet Disorders: Current Status and Future Options	3

GTH News	3
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	3
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia	3
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	3
Platelets and COVID-19	3
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	2
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	2
Treatment of Atypical Clots	2
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia	2
Haemostaseological pearls	2
Venous Thromboembolism Issues in Women	2
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry	2
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]	2
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	2
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP	2
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	2
GTH News	2
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	2
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability	2
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	2
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	2
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay	2
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	2
	2
Treatment Burden during a Phase 3 Randomized, Crossover Study of Recombinant ADAMTS13 Prophylaxis and Standard of Care in Patients with Congenital Thrombotic Thrombocytopenic Purpura	1
Management of Vascular Thrombosis in Patients with Thrombocytopenia	1
Apixaban for thromboprophylaxis in paediatric cardiology patients – Real-world data from a single institution	1
The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study	1
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry	1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications	1
	1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	1
First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study	1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	1
Animal and Cellular Models in Thrombosis and Hemostasis	1
Platelet Dysregulation in the Pathobiology of COVID-19	1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL	1
Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities	1
Leichte Schlaganfälle: Thrombolyse und routinemäßige medi-zinische Versorgung im Vergleich	1
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH	1
Glycoprotein-specific antibodies modulates platelet phenotypes in an epitope-dependent manner	1
Erhöhte Faktor-VIII-Aktivität – gesteigertes Risiko für Pfortaderthrombosen	1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis	1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern	1
The evidence of enlarged platelets with reduced expression of glycoprotein Ib/IX might indicate recessive inherited thrombocytopenias other than Bernard-Soulier Syndrome	1
GTH News	1
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management	1
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning	1
Microvascular Skin Manifestations Caused by COVID-19	1
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	1
Advancing Treatment Options: Two Phase 3 Studies Investigating the Efficacy, Safety, and Pharmacokinetics of an Antithrombin Concentrate in Patients with Congenital and Acquired Antithrombin Deficienc	1
Feasibility of a VWF:Ag latex immunoassay on a fully automated coagulation analyzer	1
Laudatio auf Rüdiger E. Scharf	1
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group	1
Promoting young talents - “Coagulation for bloody beginners” („Gerinnung für blutige Anfänger*innen“)	1
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes	1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting	1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)	1
Managing immune thrombocytopenia (ITP) during pregnancy- Single centre 15 years experience at a tertiary care institute	1
Intravital Imaging of Thrombosis Models in Mice	1
Fibrin exposition on the surface of the remaining part of arterial thrombus arrests the thrombus growth	1
Evaluating the prevalence and profile of antibodies against Polyethylene Glycol in hemophilia patients and healthy Individuals	1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
vWF/GPIb mechano-dependent interactions require F-actin disassembly by the oxidoreductase MICAL1	1
Noncanonical Regulation of ACKR3/CXCR7 on Lipid Mediators in Immunothrombotic Platelet Response following FcγRIIa Stimulation	1
Comparing thrombin generation in hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation	0
	0
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism	0
TFPI deletion in myeloid cells exacerbates atherosclerotic plaque development	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Update on Cancer-Associated Venous Thromboembolism in Children	0
Thiol isomerase inhibition with bacitracin or rutin interferes with tissue factor production in myelomonocytic HL-60 cells and isolated AML blasts	0
Pitfalls in Coagulation Testing	0
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0

Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	0
Paving the way to assay automation: Improving and simplifying VWF activity determination of VWF concentrates	0
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	0
GTH News	0
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia	0
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia	0
COVID-19: Cardio-pulmonary and Vascular Manifestations	0
Detection of joint bleeding symptoms in Haemophilia with the Noraxon system – pilot study	0
	0
Perioperative Management with Efanesoctocog Alfa in Adults, Adolescents, and Children with Severe Hemophilia A in the Phase 3 XTEND Clinical Program	0
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction	0
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec	0
Compassionate use of osocimab in preventing thrombotic complications without incremental bleeding: a case report	0
Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
A Novel Rapid Clotting Assay for Tissue Factor Pathway inhibitor (TFPI)	0
Im letzten Augenblick verhindert: Geplante Übertragung der Richtlinienbefugnis bezüglich Herstellung und Anwendung von Blut und Blutprodukten von der Bundesärztekammer (BÄK) auf das Paul-Ehrlich-Insti	0
Tackling the implementation hurdle: User-centric validation of a machine-learning decision support tool for the screening of mild bleeding disorders	0
New Anticoagulants in Neonates, Children, and Adolescents	0
Venous thromboembolism therapy with edoxaban in daily - care patients: results from the DRESDEN NOAC REGISTRY	0
Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)	0
Analysis of the platelet activation profile in a novel experimental mouse model of AAA formation and progression	0
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
Development of an innovative approach based on targeted anticoagulation for the treatment of VTE	0
Disorders of Thrombosis and Hemostasis in Cancer	0
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	0
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review	0
	0
	0
Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia: a prospective validation study	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	0
Controlling Patient Multiple Electrode Aggregometry Results with Blood Samples of Blood Donors Improves Clinical Interpretation	0
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	0
Hemostasis modification in the presence of concizumab combined with donors' platelets, rFVIIa and/or tranexamic acid assessed by modified rotational thromboelastometry in patients with Glanzm	0
Pulmonary Embolism: Don't Start Me to Talkin'	0
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
Plasma factors might interfere with platelet function in patients with decompensated liver cirrhosis	0
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
GPVI-mediated platelet activation aggravates inflammation and progressive aortic wall remodelling in abdominal aortic aneurysm formation	0
Combining Diagnostics and Research in an Academic Laboratory	0
Joint health and physical activity in people with haemophilia A without factor VIII inhibitors before switching to emicizumab prophylaxis: Beyond ABR study interim analysis	0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0
Platelet desialylation is mediated by upregulated plasmatic neuraminidase activity and linked to platelet dysfunction in sepsis	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Natural history of isolated distal deep vein thrombosis without anticoagulation. Prospective cohort under ultrasound surveillance	0
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro	0
Epithelial thrombin-PAR1 signaling and Nippostrongylus brasiliensis infection drive small intestinal villus vascularization	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
Specific reversal of factor Xa inhibitors with single domain antibodies	0
	0
Thrombotic Ghost as a Complication of Anticoagulation Therapy: The Challenge of Anticoagulating Intracardiac Thrombi in Patients with Factor VII Deficiency	0
VTE Risk Assessment and Prevention in Pregnancy	0
Severe autoimmune Heparin Induced Thrombocytopenia with persistence over years: a case report	0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature	0
Applicability of and adherence to anticoagulation-related standard-operating-procedures in standard surgical procedures – a single center quality control experience	0
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten	0
Von Willebrand Disease—Specific Aspects in Women	0
Double CRISPR/Cas9-knockout of ER chaperones, ERGIC transporters and GABARAPs reveal additive and dominant effect on FVIII secretion	0
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	0
Assessment of plasma levels of D-dimer and prothrombin fragment 1+2 in patients on direct oral anticoagulants versus vitamin K antagonists	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	0
Etranacogene dezaparvovec hemophilia B gene therapy phase 2b trial final results: stable and durable FIX level expression over 5 years [ENCORE]	0
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	0
Aspects of long-term joint health in haemophilia A: inSight Joint Health tool	0
Pulmonary Hypertension and COVID-19	0
Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
Hemostaseology in Pediatrics	0
	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)	0
Molecular Genetics of Fletcher and Fitzgerald Traits	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
Clinical and Functional Assessment of Elderly Patients with Haemophilia	0
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	0
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1	0
Procoagulant Platelets as a Compensatory Mechanism and Their Impact on Bleeding Severity in Hemophilia A	0
A reinforced fibrin- and platelet-rich layer on the exterior surface of hemostatic blood clots in vivo is formed by platelet contraction	0
	0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors	0
Priv.-Doz. Dr. med. Rainer B. Zotz	0
In-vitro Evaluation of Anti-PEG Antibody Effects on the Activation of PEGylated Therapeutic FVIII and FIX Products	0
Grundlagen zur Anwendung von Andexanet	0
FXIa-Triggered Thrombin Generation to Predict Breakthrough Bleeding in Acquired Hemophilia A: Data from the GTH-AHA-EMI Study	0
Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All	0
VITT-like anti-PF4 antibodies need to be considered in patients with thrombocytopenia and thrombosis	0
The change in factor VIII therapy in Germany - a follow-up retrospective data analysis from smart medication ScanDoc over four years	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor	0